Economic Burden of Herpes Zoster (“culebrilla”) in Latin America | Zendy

Emmanouil Rampakakis | Zendy; Clare Pollock | Zendy; Claudia Vujacich | Zendy; Joao Toniolo Neto | Zendy; Alejandro Ortiz Covarrubias | Zendy; Homero Monsanto | Zendy; Kelly Johnson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Economic Burden of Herpes Zoster (“culebrilla”) in Latin America

Author(s) -

Emmanouil Rampakakis,

Clare Pollock,

Claudia Vujacich,

Joao Toniolo Neto,

Alejandro Ortiz Covarrubias,

Homero Monsanto,

Kelly Johnson

Publication year - 2017

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2017.02.021

Subject(s) - medicine , indirect costs , rash , postherpetic neuralgia , incidence (geometry) , health care , presenteeism , emergency medicine , pediatrics , surgery , absenteeism , neuropathic pain , business , psychology , physics , accounting , economics , optics , pharmacology , economic growth , social psychology

Herpes zoster (HZ) is characterized by debilitating pain and blistering dermatomal rash. The most common complication of HZ is postherpetic neuralgia (PHN), a persistent pain that can substantially affect patients' quality of life. HZ has significant impact on patients' lives with considerable implications for healthcare systems and society. The purpose of this study was to evaluate the healthcare resource utilization (HCRU) and medical costs associated with HZ in Latin America.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research